KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
KYTH was delisted on the 30th of September, 2015.
143 hedge funds and large institutions have $1.61B invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2015 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 52 increasing their positions, 38 reducing their positions, and 44 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 4 → 12 (+8)
37% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 38
3% less capital invested
Capital invested by funds: $1.66B → $1.61B (-$54.9M)
7% less funds holding
Funds holding: 153 → 143 (-10)
20% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 44
23% less call options, than puts
Call options by funds: $17.6M | Put options by funds: $22.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$64.9M |
| 2 |
GF
Gabelli Funds
Rye,
New York
|
+$59.7M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$50.8M |
| 4 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$35M |
| 5 |
Morgan Stanley
New York
|
+$20.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$54.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$49.7M |
| 3 |
Jennison Associates
New York
|
-$44.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$41.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$36.3M |
KYTH Hedge Fund Activity: Q3 2015 in Review
143 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q3 2015, worth a combined $1.61B — down 3.3% from $1.66B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of KYTH and 35 opened new positions — a net loss of 9 holders — while 38 trimmed existing stakes and 52 added.
The largest buyer was AQR Arbitrage, adding an estimated $64.9M. The largest seller was AllianceBernstein, cutting an estimated $54.4M.
- 143 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q3 2015, down from 153 in Q2 2015.
- Funds reported $1.61B of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q3 2015, down 3.3% quarter-over-quarter.
- 35 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q3 2015 and 44 closed out, a net change of -9 holders.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q3 2015 was AQR Arbitrage, an estimated $64.9M added.
- The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q3 2015 was AllianceBernstein, an estimated $54.4M sold.
Based on aggregated 13F filings for Q3 2015.